Physician profile
Crystal A Johnson
NPI 1477925568
$1,846.34
in general payments reported to CMS, 2019-2025
18 companies · $923 in 2025
The $923 reported for 2025 was more than what 79% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.63 · 2023: $56.13 · 2024: $837 · 2025: $923.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,727 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,726.72 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $284.00 | 2024-2025 | Caplyta |
| Abbvie INC. | $230.58 | 2024-2025 | |
| Axsome Therapeutics, INC. | $202.89 | 2024-2025 | Auvelity |
| Alkermes, INC. | $169.02 | 2024-2025 | Aristada, Lybalvi |
| Teva Pharmaceuticals USA, INC. | $136.82 | 2024-2025 | Austedo Xr, Austedo Xr |
| Harmony Biosciences LLC | $132.80 | 2024 | |
| Neurocrine Biosciences, INC. | $124.11 | 2024-2025 | Ingrezza |
| Ironshore Pharmaceuticals INC. | $121.72 | 2024 | |
| Janssen Pharmaceuticals, INC | $114.75 | 2025 | Spravato |
| Noven Therapeutics, LLC | $90.72 | 2024-2025 | Xelstrym, Secuado |
| Corium, LLC | $85.00 | 2024 | Azstarys |
| Collegium Pharmaceutical, INC. | $36.62 | 2025 | Jornay Pm |
| Organogenesis INC. | $34.14 | 2023 | Puraply |
| Boston Scientific Corporation | $21.99 | 2023 | Wavewriter Alpha Prime 16 |
| Vanda Pharmaceuticals INC. | $17.71 | 2024 | Fanapt, Hetlioz |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Almatica Pharma LLC | $17.67 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.84 | 2025 | Trintellix |
| Uswm, LLC | $11.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Crystal Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.